Assessment of version 2.5 of QMAC-dRAST for rapid antimicrobial susceptibility testing with reduced sample-to-answer turnaround time and an integrated expert system.

Journal: Infectious diseases now
PMID:

Abstract

OBJECTIVE: To assess the performance of the new rapid antimicrobial susceptibility testing (AST) QMAC-dRAST V2.5 system.

Authors

  • Patrick Grohs
    Microbiology department, Georges-Pompidou European Hospital, AP-HP, Centre - Université de Paris, Paris, France. Electronic address: patrick.grohs@aphp.fr.
  • Simon Picard
    Microbiology department, Georges-Pompidou European Hospital, AP-HP, Centre - Université de Paris, Paris, France.
  • Jean-Luc Mainardi
    Microbiology department, Georges-Pompidou European Hospital, AP-HP, Centre - Université de Paris, Paris, France.
  • Isabelle Podglajen
    Microbiology department, Georges-Pompidou European Hospital, AP-HP, Centre - Université de Paris, Paris, France.